Monoamine oxidase inhibitory activity in tobacco smoke varies with tobacco type

被引:26
|
作者
Lewis, Amy J. [1 ,2 ]
Truman, Penelope [1 ]
Hosking, Matthew R. [1 ]
Miller, John H. [2 ]
机构
[1] Inst Environm Sci & Res Ltd, Porirua, New Zealand
[2] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand
关键词
D O I
10.1136/tc.2010.040287
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background It has been suggested that inhibition of monoamine oxidase (MAO) activity by components of cigarette smoke may impact on smoking addiction, but it is unclear to what extent the known MAO inhibitors in tobacco smoke cause this inhibition. Methods MAO inhibitory activity was measured in a series of tobacco particulate matter preparations from different brands of cigarette and loose-leaf tobacco commonly available in New Zealand. Results When tobacco extracts were diluted to contain a physiologically relevant nicotine concentration of 0.2 mu M, all samples tested inhibited MAO-A and MAO-B by between 4% and 12% in a standard assay. Per mg of nicotine, samples from factory-made cigarettes contained significantly less MAO inhibitory activity than did samples from loose-leaf tobacco. When inhibitory activity was calculated on a per mg of tar basis, there was no significant difference between loose-leaf tobaccos and factory-made cigarettes. Conclusions The present study shows that the ratio of nicotine to MAO inhibitory activity varies depending on the type of tobacco product used. The roll-your-own tobaccos tested delivered more tar and more MAO inhibitory activity per mg of nicotine than the factory-made cigarettes. These findings suggest that smokers of roll-your-own tobacco may experience greater difficulty in stopping smoking.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 50 条
  • [41] Comparison of monoamine oxidase inhibition by cigarettes and modified risk tobacco products
    van der Toorn, Marco
    Koshibu, Kyoko
    Schlage, Walter K.
    Majeed, Shoaib
    Pospisil, Pavel
    Hoeng, Julia
    Peitsch, Manuel C.
    TOXICOLOGY REPORTS, 2019, 6 : 1206 - 1215
  • [42] PERSONALITY-TRAITS AND PLATELET MONOAMINE-OXIDASE IN TOBACCO SMOKERS
    VONKNORRING, L
    ORELAND, L
    PSYCHOLOGICAL MEDICINE, 1985, 15 (02) : 327 - 334
  • [43] EFFECTS OF TOBACCO-SMOKE ON MUCOCILIARY ACTIVITY
    VOGIN, EE
    SCHEIMBE.J
    RUBENSTE.C
    CARSON, S
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1972, 22 (02) : 322 - &
  • [44] THE MUTAGENIC AND CLASTOGENIC ACTIVITY OF TOBACCO-SMOKE
    BALANSKY, RM
    BLAGOEVA, PM
    MIRCHEVA, ZI
    MUTATION RESEARCH, 1988, 208 (3-4): : 237 - 241
  • [45] A hypothesis for an alternative treatment for tobacco addiction: phenelzine, a monoamine oxidase inhibitor
    Curran, C. A.
    Boshes, R. A.
    Lee, D. Y.
    Curran, P. M. Coratti
    Hott, B.
    TOBACCO INDUCED DISEASES, 2018, 16 : 132 - 132
  • [46] INVESTIGATION OF THE MUTAGENIC ACTIVITY OF TOBACCO-SMOKE
    BALANSKY, RM
    BLAGOEVA, PM
    MIRCHEVA, ZI
    MUTATION RESEARCH, 1987, 188 (01): : 13 - 19
  • [47] Inhibitory activity of monoamine oxidase by coumarins fromPeucedanum japonicum
    Dang Thi Lan Huong
    Hee Cheol Choi
    Tae Cheol Rho
    Hyun Sun Lee
    Myung Koo Lee
    Young Ho Kim
    Archives of Pharmacal Research, 1999, 22 : 324 - 326
  • [48] ENHANCED MONOAMINE-OXIDASE INHIBITORY ACTIVITY OF TRANYLCYPROMINE
    POP, E
    ANDERSON, W
    BREWSTER, ME
    BODOR, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 68 - MEDI
  • [49] TOBACCO-SPECIFIC NITROSAMINES IN TOBACCO AND TOBACCO-SMOKE
    HECHT, SS
    ADAMS, JD
    HOFFMANN, D
    IARC PUBLICATIONS, 1983, (45): : 93 - 101
  • [50] SYNTHESIS OF SULFONYLHYDRAZINE DERIVATIVES WITH MONOAMINE OXIDASE INHIBITORY ACTIVITY
    ROONEY, CS
    CRAGOE, EJ
    PORTER, CC
    SPRAGUE, JM
    JOURNAL OF MEDICINAL & PHARMACEUTICAL CHEMISTRY, 1962, 5 (01): : 155 - &